QIAGEN N.V. (QGEN) /

The cash flow of QIAGEN N.V. over the past 10 years

Chart QIAGEN N.V.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, QIAGEN N.V.'s operating cash flow was $654.33M and its capital expenditures $201.05M, leaving free cash flow of $453.28M. Free cash flow was above zero in all 10 years shown. It ranged from $196.7M in fiscal 2017 to $586.04M in fiscal 2022. Capital expenditures were highest in fiscal 2025, at $201.05M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$654.33M$201.05M$453.28M
2024ended Dec 31, 2024$673.55M$167.17M$506.38M
2023ended Dec 31, 2023$459.45M$149.71M$309.75M
2022ended Dec 31, 2022$715.26M$129.22M$586.04M
2021ended Dec 31, 2021$639M$189.9M$449.1M
2020ended Dec 31, 2020$457.81M$132.79M$325.02M
2019ended Dec 31, 2019$330.84M$117.95M$212.89M
2018ended Dec 31, 2018$359.5M$109.77M$249.72M
2017ended Dec 31, 2017$286.78M$90.08M$196.7M
2016ended Dec 31, 2016$341.6M$74.54M$267.07M

Fiscal years as QIAGEN N.V. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on QIAGEN N.V.

Companies of a similar size

Not investment advice. This page shows what QIAGEN N.V. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.